pharma news

News

Lilly becomes first $1trn+ pharma company

Eli Lilly has become the first pharma group to reach a value of more than $1 trillion, joining a select group populated mainly by tech giants.

News

Overweight man leans on office desk with female co-worker

Waltz dances into direct-to-employer sales of obesity drugs

Waltz Health is planning to disrupt the weight-loss therapy market in the US with a new direct-to-employer sales channel.

News

Neuralink rival Paradromics cleared to start speech trial

Brain computer interface developer Paradromics has been cleared to start a US clinical trial of its Connexus implant for speech restoration.

News

Alnylam's ATTR cardiomyopathy drug backed for NHS use

Patients with ATTR-CM in England and Wales will soon have a new treatment option, after NICE backed use of Alnylam's three-month injectable Amvuttra.

News

ADC specialist Solve raises $120m, and other biofinancings

Our round-up of biofinancings is led by a $120m round for ADC specialist Solve, with Aspen, Artios, Profluent, and Gate Bioscience also raising funds.

News

Gloved hand punches a karate pad held up

GSK unit and AnaptysBio trade lawsuits over Jemperli

A spat between GSK/Tesaro and AnaptysBio over cancer drug Jemperli has escalated into litigation, with both parties claiming breach of contract.

Lilly becomes first $1trn+ pharma company

Waltz dances into direct-to-employer sales of obesity drugs

Neuralink rival Paradromics cleared to start speech trial

Alnylam's ATTR cardiomyopathy drug backed for NHS use

ADC specialist Solve raises $120m, and other biofinancings

GSK unit and AnaptysBio trade lawsuits over Jemperli

Patent losses hit Novartis hard, but CEO has a plan

How to meet your physicians where they are online

pharma news

Editor's Picks